CAS: 173529-46-9 - (E)-N-Acetyl-4-methoxy-N-[2-[2-(1-oxidopyridin-4-yl)vinyl]phenyl]benzenesulfonamide
Fórmula:C22H20N2O5S
InChI:InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+
Clave InChI:InChIKey=OCKHRKSTDPOHEN-BQYQJAHWSA-N
SMILES:O=C(N(C=1C=CC=CC1C=CC2=CC=N(=O)C=C2)S(=O)(=O)C3=CC=C(OC)C=C3)C
- Sinónimos:
- (E)-4-[2-[2-[N-Acetyl-N-[(p-methoxyphenyl)sulfonyl]amino]phenyl]ethenyl]pyridine 1-oxide
- Acetamide, N-[(4-methoxyphenyl)sulfonyl]-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]-
- Acetamide, N-[(4-methoxyphenyl)sulfonyl]-N-[2-[2-(1-oxido-4-pyridinyl)ethenyl]phenyl]-, (E)-
- Hmn-214
- Ivx 214
- N-[(4-Methoxyphenyl)sulfonyl]-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]acetamide
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Acetamide, N-[(4-methoxyphenyl)sulfonyl]-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]- REF: AN-AG001Z05CAS: 173529-46-9 | 98% | 47,00 €~479,00 € | Mar 07 May 24 | |
HMN-214 REF: TM-T2438CAS: 173529-46-9 | 100% | 40,00 €~1.096,00 € | Mar 14 May 24 | |
HMN-214 REF: 3D-FH170580CAS: 173529-46-9 | Min. 95% | A consultar | Mar 18 Jun 24 |
Acetamide, N-[(4-methoxyphenyl)sulfonyl]-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]-
CAS:173529-46-9
Fórmula:
C22H20N2O5S
Pureza:
98%
Forma y color:
Solid
Peso molecular:
424.4696
Ref: AN-AG001Z05
1mg | 47,00 € | |
5mg | 101,00 € | |
10mg | 126,00 € | |
25mg | 189,00 € | |
50mg | 206,00 € | |
100mg | 312,00 € | |
250mg | 479,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Mayo de 2024
HMN-214
CAS:173529-46-9
HMN-214 (IVX-214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
Fórmula:
C22H20N2O5S
Pureza:
100%
Forma y color:
Solid
Peso molecular:
424.47
Ref: TM-T2438
1mg | 40,00 € | |
2mg | 57,00 € | |
5mg | 88,00 € | |
10mg | 127,00 € | |
25mg | 220,00 € | |
50mg | 350,00 € | |
100mg | 500,00 € | |
500mg | 1.096,00 € | |
1ml*10 (DMSO) | 90,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Mayo de 2024
HMN-214
CAS:173529-46-9
HMN-214 is a novel oral prodrug that is being developed as a single agent therapy …
Fórmula:
C22H20N2O5S
Pureza:
Min. 95%
Peso molecular:
424.47 g/mol
Ref: 3D-FH170580
1mg | A consultar | |
2mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Junio de 2024